Publication:


abstract

BACKGROUND:

We investigated the Associations between second trimester amniotic fluid (AF) levels of human adiponectin and placental growth factor (PLGF) in small for gestational age (SGA), large for gestational age (LGA) and appropriate for gestational age (AGA) fetuses.

MATERIALS AND METHODS:

Adiponectin and PLGF levels were determined by enzyme immunoassay in AF of 21 SGA, 13 LGA and 44 AGA fetuses between 15-22 weeks of gestation, derived from pregnant women who underwent amniocentesis.

RESULTS:

Adiponectin and PLGF levels were detectable in AF. Median (25th-75th percentile) adiponectin levels were 16.1 (10.9-32.3) ng/ml in SGA, 19.5 (15.1-30.9) ng/ml in AGA, and 18.2 (14.7-30.8) ng/ml in LGA fetuses. Median (25th-75th percentile) PLGF levels were 24.2 (19.9-34.9) pg/nl in SGA, 26.4 (20.9-33.8) pg/ml in AGA and 33.5 (21.8-40.4) pg/ml in LGA fetuses. The differences were not statistically significant. Nevertheless, indication of differentiation of levels existed when SGA and LGA fetuses in the extremes of distribution were considered. Specifically, very severely SGA fetuses (≤2.5th percentile) tended to have high levels of adiponectin and reduced levels of PLGF in AF.

CONCLUSION:

This is the first study presenting adiponectin and PLGF concentrations in early second trimester amniotic fluid in AGA, SGA and LGA fetuses. The altered concentrations of adiponectin and PLGF in very severely SGA fetuses possibly result from the growth-promoting effect of these factors through the metabolic route and the vascular integrity of the placenta, respectively.

Related Articles
Hepatocyte growth factor concentration in the early second-trimester amniotic fluid does not predict fetal growth at birth.
Hum Reprod. 1999
Hepatocyte growth factor concentration in the early second-trimester amniotic fluid does not predict fetal growth at birth.
Ohnishi Y, Yamashiro C, Yanagihara T, Hata T. Hum Reprod. 1999 Oct; 14(10):2625-8.
Amniotic fluid insulin-like growth factor binding protein 3 concentration as early indicator of fetal growth restriction.
Eur J Obstet Gynecol Reprod Bi...
Amniotic fluid insulin-like growth factor binding protein 3 concentration as early indicator of fetal growth restriction.
Murisier-Petetin G, Gremlich S, Damnon F, Reymondin D, Hohlfeld P, Gerber S. Eur J Obstet Gynecol Reprod Biol. 2009 May; 144(1):15-20. Epub 2009 Feb 13.
The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.
J Matern Fetal Neonatal Med. 2...
The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.
Erez O, Romero R, Espinoza J, Fu W, Todem D, Kusanovic JP, Gotsch F, Edwin S, Nien JK, Chaiworapongsa T, et al. J Matern Fetal Neonatal Med. 2008 May; 21(5):279-87.
Second-trimester amniotic fluid or maternal serum interleukin-10 levels and small for gestational age neonates.
Obstet Gynecol. 1996
Second-trimester amniotic fluid or maternal serum interleukin-10 levels and small for gestational age neonates.
Spong CY, Sherer DM, Ghidini A, Jenkins CB, Seydel FD, Eglinton GS. Obstet Gynecol. 1996 Jul; 88(1):24-8.
A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
J Matern Fetal Neonatal Med. 2...
A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.
Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, Kusanovic JP, Gotsch F, Erez O, Mazaki-Tovi S, et al. J Matern Fetal Neonatal Med. 2008 Jan; 21(1):9-23.